Topical application of dimethylbenz[a]anthracene results in the generation of multiple melanocytic nevi in C3H/HeN mice

Toxicology and Applied Pharmacology

Volumn 195, Issue 3, 2004, Pages 355-360

  Elmets, Craig A ^a,b   Yusuf, Nabiha ^a   Hamza, Sate ^a   Iranikakh, Nasser ^a   Smith, Jeffrey ^a,b   Volk, Andrea L ^a   Skelton, Henry ^b   Smith, Kathy ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

12 O tetradecanoyl phorbol 13 acetate; Dimethylbenz(a)anthracene; Dimethylbenz a anthracene; DMBA; Melanocytic nevi; Melanoma; PAH; Polyaromatic hydrocarbon; TPA

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; PROTEIN S 100; XENOBIOTIC AGENT;

ANIMAL MODEL; ARTICLE; BENIGN TUMOR; BIOACCUMULATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; HISTOLOGY; MEDICAL EXAMINATION; MELANOCYTIC NEVUS; MELANOMA; MOLECULAR EVOLUTION; MOUSE; NEVUS CELL; NONHUMAN;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, CUTANEOUS; ANIMALS; CARCINOGENICITY TESTS; COCARCINOGENESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; MICE, INBRED C3H; NEVUS, PIGMENTED; PHORBOL ESTERS; SKIN; SKIN NEOPLASMS;

ANIMALIA;

EID: 1542722128     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.09.029     Document Type: Article

References (27)

1. Anderson C., Hehr A., Robbins R., Hasan R., Athar M., Mukhtar H., Elmets C.A. Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J. Immunol. 155:1995;3530-3537.
2. Barnhill R.L., Llewellyn K. Benign melanocytic neoplasms. Bolognia J.L., Jorizzo J.L., Rapini R.P., Horn T.D., Mascaro J.M., Saurat J.-H., Mancini A.J., Salasche S.J., Stingl G. Dermatology. 2003;1768-1769 Mosby, London.
3. Bastian B.C., LeBoit P.E., Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am. J. Pathol. 157:2000;967-972.
4. Bizub D., Wood A.W., Skalka A.M. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. U.S.A. 83:1986;6048-6052.
5. Brown K., Buchmann A., Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. U.S.A. 87:1990;538-542.
6. Colombari R., Bonetti F., Zamboni G., Scarpa A., Marino F., Tomezzoli A., Capelli P., Menestrina F., Chilosi M., Fiore-Donati L. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections. Virchows Arch. A: Pathol. Anat. Histopathol. 413:1988;17-24.
7. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polyaromatic hydrocarbons. Cancer Res. 42:1982;4875-4917.
8. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54:1992;63-128.
9. DiGiovanni J. Genetic factors controlling responsiveness to skin tumor promotion in mice. Prog. Clin. Biol. Res. 391:1995;195-212.
10. Elmets C.A., Zaidi S.I., Bickers D.R., Mukhtar H. Immunogenetic influences on the initiation stage of the cutaneous chemical carcinogenesis pathway. Cancer Res. 52:1992;6106-6109.
11. Elmets C., Athar M., Tubesing K., Rothaupt D., Xu H., Mukhtar H. Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14915-14919.
12. Gallagher R.P., Rivers J.K., Lee T.K., Bajdik C.D., McLean D.I., Coldman A.J. Broad-spectrum sunscreen use and the development of new nevi in children. JAMA. 283:2000;2955-2960.
13. Gown A.M., Vogel A.M., Hoak D., Gough F., McNutt M.A. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am. J. Pathol. 123:1986;195-203.
14. Hoang M.P., Prieto V.G., Burchette J.L., Shea C.R. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J. Cutaneous Pathol. 28:2001;400-406.
15. Klemme J., Mukhtar H., Elmets C. Induction of contact hypersensitivity to dimethylben[a]anthracene and benzo[a]pyrene in C3H/HeN mice. Cancer Res. 47:1987;6074-6078.
16. Nakajima T., Watanabe S., Sato Y., Kameya T., Shimosato Y., Ishihara K. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer. 50:1982;912-918.
17. Papp T., Pemsel H., Zimmermann R., Bastrop R., Weiss D.G., Schiffmann D. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet. 36:1999;610-614.
18. Pelling J.C., Fischer S.M., Neades R., Strawhecker J., Schweickert L. Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents. Carcinogenesis. 8:1987;1481-1484.
19. Pelling J.C., Sheng X., Betz N.A. Role of Ha-ras oncogene in skin cancer. Mukhtar H. Skin Cancer: Mechanisms and Human Relevance. 1995;283-291 CRC Press, Boca Raton, FL.
20. Penneys N. Examination of melanoma after initial biopsy. An immunohistochemical study. J. Am. Acad. Dermatol. 13:1985;995-998.
21. Perluigi M., De Marco F., Foppoli C., Coccia R., Blarzino C., Marcante M.L., Cini C. Tyrosinase protects human melanocytes from ROS-generating compounds. Biochem. Biophys. Res. Commun. 305:2003;250-256.
22. Platz A., Ringborg U., Grafstrom E., Hoog A., Lagerlof B. Immunohistochemical analysis of N-ras p21 and the p53 proteins in naevi, primary tumors and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Res. 5:1995;101-106.
23. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 322:1986;78-80.
24. Ruby J., Halliday G., Muller H. Differential effects of benzo[a]pyrene and dimethylbenz[a]-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis. J. Invest. Dermatol. 92:1989;150-160.
25. Slaga T.J. Mechanisms of tumor promotion. Slaga T.J. Tumor Promotion and Skin Carcinogenesis. 1984;1-16 CRC Press, Boca Raton, FL.
26. Thurmond L., Lauer L., House R., Cook J., Dean J. Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice. Toxicol. Appl. Pharmacol. 91:1987;450-460.
27. Winberg L.D., Budnova I.V., Warren B.S., Iyer R.P., Slaga T.J. Mechanisms of skin tumor promotion and progression. Mukhtar H. Skin Cancer: Mechanisms and Human Relevance. 1995;113-120 CRC Press, Boca Raton, FL.